Search Results - "Chaher, Nabila"
-
1
Comparative aspects of canine and human inflammatory breast cancer
Published in Seminars in oncology (01-08-2017)“…Inflammatory breast cancer (IBC) in humans is the most aggressive form of mammary gland cancer and shares clinical, pathologic, and molecular patterns of…”
Get full text
Journal Article -
2
Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients
Published in Breast cancer research and treatment (01-12-2021)“…Purpose This study evaluated epidemiologic and immune factors associated with pathologic complete response (pCR), breast cancer-specific survival (BCSS) and…”
Get full text
Journal Article -
3
Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer
Published in BMC cancer (19-07-2012)“…Inflammatory breast cancer (IBC) is a highly angiogenic disease; thus, antiangiogenic therapy should result in a clinical response. However, clinical trials…”
Get full text
Journal Article -
4
Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients
Published in Breast cancer research and treatment (01-01-2012)“…Inflammatory breast cancer (IBC) shows a high incidence in Tunisia and Egypt but epidemiological and molecular characteristics have not been described in…”
Get full text
Journal Article -
5
Abstract P5-09-03: Expression of the C9Orf72 long-isoform in cancer tissues prognosticates disease-free and breast cancer-specific survival
Published in Cancer research (Chicago, Ill.) (01-05-2015)“…Abstract Background: An expansion of the GGGGCC hexanucleotide repeat in C9Orf72 gene promoter results in reduced mRNA expression of its long-isoform, and has…”
Get full text
Journal Article -
6
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
Published in Breast cancer research and treatment (01-08-2010)“…GPR30 is a novel G protein-coupled estrogen receptor (ER) associated with metastases in breast cancer (BC) and poor survival in endometrial and ovarian tumors…”
Get full text
Journal Article